Skip to content
God Of Sound – Lifestyle
Author:
VANDA PHARMACEUTICALS INC
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists
April 8, 2026
←
Previous Page
1
2